TH86008A - - Google Patents

Info

Publication number
TH86008A
TH86008A TH401001469A TH0401001469A TH86008A TH 86008 A TH86008 A TH 86008A TH 401001469 A TH401001469 A TH 401001469A TH 0401001469 A TH0401001469 A TH 0401001469A TH 86008 A TH86008 A TH 86008A
Authority
TH
Thailand
Prior art keywords
interleukin
antitumor
pharmaceutical mixtures
antagonist
antagonists
Prior art date
Application number
TH401001469A
Other languages
English (en)
Thai (th)
Other versions
TH86008B (th
Original Assignee
นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง filed Critical นางดารานีย์ วัจนะวุฒิวงศ์ นางสาวสนธยา สังขพงศ์ นายณัฐพล อร่ามเมือง
Publication of TH86008A publication Critical patent/TH86008A/th
Publication of TH86008B publication Critical patent/TH86008B/th

Links

TH401001469A 2004-04-26 วิธีการสำหรับบำ บัดรักษาโรคที่มีลักษณะเกี่ยวข้องกับอินเตอร์ลิวคิน-6 TH86008B (th)

Publications (2)

Publication Number Publication Date
TH86008A true TH86008A (ja) 2007-08-20
TH86008B TH86008B (th) 2007-08-20

Family

ID=

Similar Documents

Publication Publication Date Title
EP2368577A3 (en) Methods for treating interleukin-6 related diseases
ES2370409T3 (es) Forma de dosificación que contiene oxicodona y naloxona.
KR20140019364A (ko) 면역-관련 및 염증성 질환의 치료에 있어서의 3-(5-아미노-2-메틸-4-옥소퀴나졸린-3(4ｈ)-일)피페리딘-2-6-디온의 용도
EP2116245A3 (en) EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders
NZ595262A (en) Use of il-23 and il-27 antagonists to treat autoimmune ocular inflammatory disease
WO2008064321A3 (en) Methods of treating chronic inflammatory diseases using a gm-csf antagonist
CR20210271A (es) Derivados de amino triazolo quinazolina 9-sustituidos como antagonistas del receptor de adenosina, composiciones farmacéuticas y su uso
BRPI0518622A2 (pt) usos de antagonistas de receptor do tipo 1 de interleucina-1(il-1r1) para a fabricaÇço de um medicamento para o tratamento de uma doenÇa respiratària; composiÇço farmacÊutica que compreende um antagonista do il-1r1 e um veÍculo fisiologicamente aceitÁvel e dispositivo de liberaÇço de medicamento
BR0206160A (pt) Uso de anticorpos anti-tnf como medicamentos no tratamento de distúrbios sépticos de pacientes anêmicos
HUP0101694A1 (hu) Gyulladásos bélbetegségek kezelésére vagy megelőzésére szolgáló, hatóanyagként IL-6 antagonistát tartalmazó készítmény
CL2003002353A1 (es) Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
BRPI0410905A (pt) inibidores de p-38
EP1539234A4 (en) METHOD FOR PREVENTING OR TREATING CELL MALIGNITY BY ADMINISTERING CD2 ANTAGONISTS
RU2006126092A (ru) Профилактическое средство против васкулита
TW200626159A (en) Therapeutic combinations comprising poly (ADP-ribose) polymerases inhibitor
JP2009544700A5 (ja)
NZ542866A (en) Compositions and methods for the therapy of inflammatory bowel disease
RU2017106172A (ru) Применение антагонистов cxcr2 для предотвращения и/или лечения периферической невропатии, вызванной химиотерапией (cipn)
EP4442321A3 (en) Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor
Lin et al. The renoprotective potential of pentoxifylline in chronic kidney disease
BRPI0617673C1 (pt) composições de inibidores de fosfodiesterase do tipo iv
Rascón-Martínez et al. Advantages of ketamine as a perioperative analgesic
CA2487362A1 (en) Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes
CN112533675A (zh) 通过递送抗OSMRβ抗体治疗皮肤疾病或病症
TH86008A (ja)